News

In order to provide effective, extended-release medication delivery, Japanese researchers have developed TUS-84, a new three-dimensional (3D) covalent organic framework (COF) having a scu-c topology for the first time. The research was published in Applied Materials & Interfaces by...

The market capitalization of the top 20 biopharmaceutical businesses worldwide has decreased by 9.1%, from $3.45 trillion in Q2 2022 to $3.14 trillion in Q3 2022, as a result of growing generic competition and a decline in demand for...

PRAC, EMA's safety committee, has completed its review of pholcodine-containing medications used to treat nonproductive (dry) cough in adults and children as well as cold and flu symptoms when combined with other active ingredients. PRAC has recommended that the...

What changes are in store for the European Human Medicines Directive and Regulation when it is amended at the end of 2022? The current European Union (EU) regulatory framework was created in 1995, and the European Medicines Agency (EMA) now...

With 100 vaccine candidates as of July 2022, Vaccines Europe has released its first pipeline evaluation of the 15 firms that make up its membership. The analysis uncovered a pipeline that uses a variety of new technology platforms to address...

A recent analysis from GlobalData estimates that by 2028, the approval of pipeline drugs will earn over $2 billion from five marketed messenger RNA (mRNA) non-vaccine products. The analytics firm claimed that despite the fact that there are currently no...

Traditional spine surgeries take hours, come with lengthy recovery times, and even have extraneous risks that a MISS surgery can bypass. Back and spine surgery is a daunting treatment that can seem risky. However, if you have tried all other...